HDO Health Awarded a Phase 2 Ohio Department of Development Technology Validation and Startup Fund (TVSF) Grant

HDO Health was recently awarded a Technology Validation and Startup Fund (TVSF) Phase 2 Grant from Ohio Third Frontier. Ohio Third Frontier is an internationally recognized, technology-based economic development initiative that is successfully changing the trajectory of Ohio’s economy. Third Frontier works with innovative startup companies across the state, making Ohio the destination for technology entrepreneurs. This robust network of resources helps take advanced ideas and turn them into new technology businesses.

HDO Health will be utilizing the non-dilutive grant funds to further develop and finalize the design for their innovative junctional tourniquet (The Journiquet™) and prepare for a Class II U.S. Federal Drug Administration (FDA) 510(k) filing and clearance as well as other company infrastructure and commercialization activities.

Point of Contact: Bryan J. Stewart | Chief Executive Officer | 904.416.65656 | bstewart@hdohealth.com